Filter by Last updated date SelectAfterBeforeFrom - To Date End Date This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Results (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Public Statement on the risk of drug interactions with Hypericum perforatum (St John's Wort) and antiretroviral medicinal products 28 February 2000 News Committee for Proprietary Medicinal Products (CPMP) 57th plenary meeting 21 February 2000 Press release Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 February 2000 News Committee for veterinary medicinal products: 52nd meeting 10 February 2000 Press release Veterinary Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 January 2000 News Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 January 2000 Press release 3rd meeting of the Committee for Orphan Medicinal Products 19 January 2000 Press release Human Rare diseases Committee for veterinary medicinal products: 51st meeting 13 January 2000 Press release Veterinary Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 December 1999 News Committee for Proprietary Medicinal Products (CPMP) 55th plenary meeting 20 December 1999 Press release 1 … 361 362 363 364 365 Page 365 of 379 366 367 368 369 … 379
Public Statement on the risk of drug interactions with Hypericum perforatum (St John's Wort) and antiretroviral medicinal products 28 February 2000 News
Committee for Proprietary Medicinal Products (CPMP) 57th plenary meeting 21 February 2000 Press release
Public statement on Insuman Infusat 100-IU/ml solution for injection in cartridges of 3.15 ml (insulin human) - Risk of leakage during use 14 February 2000 News
Public Statement on Ziagen (Abacavir) - Important safety Information on Hypersensitivity Reactions and Respiratory Symptoms 24 January 2000 News
Committee for Proprietary Medicinal Products (CPMP) 56th plenary meeting 24 January 2000 Press release
3rd meeting of the Committee for Orphan Medicinal Products 19 January 2000 Press release Human Rare diseases
Public Statement on Rapilysin (Reteplase) - Incompatibility with Heparin and Precipitation following the Reconstitution - Important New Instructions for Use 23 December 1999 News
Committee for Proprietary Medicinal Products (CPMP) 55th plenary meeting 20 December 1999 Press release